Avantor Inc
NYSE:AVTR

Watchlist Manager
Avantor Inc Logo
Avantor Inc
NYSE:AVTR
Watchlist
Price: 20.78 USD 2.06% Market Closed
Market Cap: 14.1B USD
Have any thoughts about
Avantor Inc?
Write Note

Avantor Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Avantor Inc
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Avantor Inc
NYSE:AVTR
Total Equity
$5.6B
CAGR 3-Years
11%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Total Equity
$49B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
9%
Danaher Corp
NYSE:DHR
Total Equity
$51.3B
CAGR 3-Years
6%
CAGR 5-Years
10%
CAGR 10-Years
8%
Mettler-Toledo International Inc
NYSE:MTD
Total Equity
-$154.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Agilent Technologies Inc
NYSE:A
Total Equity
$5.9B
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
0%
IQVIA Holdings Inc
NYSE:IQV
Total Equity
$7B
CAGR 3-Years
6%
CAGR 5-Years
3%
CAGR 10-Years
N/A
No Stocks Found

Avantor Inc
Glance View

Market Cap
14.1B USD
Industry
Life Sciences Tools & Services

Avantor Inc. is a global leader in providing mission-critical products and services to customers in the life sciences and advanced technology sectors. Founded in 1904, the company has evolved from a small laboratory supply provider to a vital player in the biotechnology, pharmaceuticals, and diagnostics industries. With a portfolio of more than 10 million high-quality products, Avantor supports research and manufacturing needs across various environments, helping scientists and engineers push the boundaries of innovation. The firm prides itself on its commitment to sustainability and operational excellence, emphasizing an integrated supply chain that ensures reliable delivery and unmatched service. As an investor, understanding Avantor’s strategic positioning in a growing industry is crucial. With increasing global healthcare demands and rising investments in research and development, Avantor stands to benefit from the burgeoning life sciences market. The company's focus on digital transformation and efficiency improvements enhances its operational capabilities, while its strategic acquisitions have broadened its offerings and market reach. Furthermore, Avantor's consistent revenue growth and robust financial performance showcase a resilient business model, making it a compelling investment opportunity for those looking to capitalize on the future of scientific progress and innovation.

AVTR Intrinsic Value
24.89 USD
Undervaluation 17%
Intrinsic Value
Price

See Also

What is Avantor Inc's Total Equity?
Total Equity
5.6B USD

Based on the financial report for Sep 30, 2024, Avantor Inc's Total Equity amounts to 5.6B USD.

What is Avantor Inc's Total Equity growth rate?
Total Equity CAGR 5Y
19%

Over the last year, the Total Equity growth was 9%. The average annual Total Equity growth rates for Avantor Inc have been 11% over the past three years , 19% over the past five years .

Back to Top